SEC Form 4 · accession 0001179110-15-013020
GILEAD SCIENCES, INC. · GILD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John C Martin
Officer — Chairman and CEO · Director
Period of report
Sep 1, 2015
Accepted (ET)
Sep 3, 2015 · 3:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882095
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 1, 2015 | M | 150,000 | $14.5025 | A | 4,098,066 | D | |
| Common StockF3 | Sep 1, 2015 | S | 50,984 | $101.8118 | D | 4,047,082 | D | |
| Common StockF4 | Sep 1, 2015 | S | 45,844 | $102.6734 | D | 4,001,238 | D | |
| Common StockF5 | Sep 1, 2015 | S | 51,672 | $103.6385 | D | 3,949,566 | D | |
| Common StockF6 | Sep 1, 2015 | S | 1,500 | $104.446 | D | 3,948,066 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock option (right to buy)F2 | $14.5025 | Sep 1, 2015 | M | 150,000 | D | — | Jan 25, 2016 | Common Stock | 150,000 | 450,000 | D |
Explanation of responses
- F1The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
- F2The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.
- F3Sale prices reported for the transactions reported here range from $101.23 to $102.23. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- F4Sale prices reported for the transactions reported here range from $102.24 to $103.24. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- F5Sale prices reported for the transactions reported here range from $103.28 to $104.23. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- F6Sale prices reported for the transactions reported here range from $104.32 to $104.53. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.